(Q42281832)
Statements
A phase II trial with docetaxel (Taxotere) in second line treatment with chemotherapy for advanced breast cancer. A study of the EORTC Early Clinical Trials Group (English)
W W ten Bokkel Huinink
A M Prove
M Piccart
W Steward
T Tursz
J Wanders
H Franklin
M Clavel
J Verweij